Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats
- 8 October 2005
- journal article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 13 (10) , 535-542
- https://doi.org/10.1080/10611860500411043
Abstract
Previously it was shown that poly(butyl cyanoacrylate) (PBCA) nanoparticles coated with polysorbate 80 are able to cross the blood-brain barrier (BBB) after i.v. administration. The objective of the present study was to investigate the influence of polysorbate 80 and doxorubicin-loading on the body distribution in rats. The biodistribution profile and brain concentration of (14)C-radiolabeled PBCA nanoparticles, polysorbate 80 coated (14)C-PBCA nanoparticles, and doxorubicin-loaded (14)C-PBCA nanoparticles were determined by radioactivity counting after i.v. administration in rats. The (14)C-PBCA nanoparticles showed a significant accumulation in the organs of the reticuloendothelial system (RES). Polysorbate 80 coating of the (14)C-PBCA nanoparticles decreased this accumulation to about 40% after 1 h post injection. The brain concentration was increased about 2-fold after polysorbate 80-coating at this time point. The presence of doxorubicin in this preparation, however, decreased the brain concentration to levels similar to uncoated particles, probably caused by the positive charge of this compound. After longer time periods after injection the differences between the three preparations decreased.Keywords
This publication has 28 references indexed in Scilit:
- Negative preclinical results with stealth® nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor modelJournal of Controlled Release, 2004
- Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticlesInternational Journal of Cancer, 2004
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain BarrierJournal of Drug Targeting, 2002
- Nanoparticle Technology for Drug Delivery Across the Blood-Brain BarrierDrug Development and Industrial Pharmacy, 2002
- Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injectionsBrain Research, 1996
- Interaction of Serum Components with Poly(methylmethacrylate) Nanoparticles and the Resulting Body Distribution after Intravenous Injection in RatsJournal of Drug Targeting, 1993
- Membrane protein structure predictionJournal of Molecular Biology, 1992
- Influence of the surface properties of low contact angle surfactants on the body distribution of14C-poly(methyl methacrylate) nanoparticlesJournal of Microencapsulation, 1992
- Distribution of Polyhexylcyanoacrylate Nanoparticles in Nude Mice over Extended Times and after Repeated InjectionJournal of Pharmaceutical Sciences, 1988